Claims for Patent: 7,429,387

✉ Email this page to a colleague

Summary for Patent: 7,429,387

Title:	Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
Abstract:	The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin.
Inventor(s):	Schmidt; Richard A. (Arvada, CO)
Assignee:	The Regents of the University of Colorado (Boulder, CO)
Application Number:	11/077,895
Patent Claims:	1. A method for treating a recalcitrant voiding dysfunction, the method comprising the step of injecting a botulinum toxin to a lateral bladder wall of a patient, thereby treating the recalcitrant voiding dysfunction. 2. The method of claim 1, wherein the patent is a human. 3. The method of claim 1, wherein the patient is a human female. 4. The method of claim 1, wherein the patient is a human male. 5. The method of claim 1, wherein the botulinum toxin is a botulinum toxin type A. 6. The method of claim 1, wherein a symptom of the recalcitrant voiding dysfunction is urinary incontinence. 7. A method for treating a recalcitrant voiding dysfunction, the method comprising the step of injecting a therapeutically effective amount of a botulinum toxin type A to a lateral bladder wall a patient, thereby treating the recalcitrant voiding dysfunction. 8. The method of claim 7, wherein the botulinum toxin type A is injected in the amount up to 2500 units. 9. The method of claim 7, wherein the therapeutically effective amount of botulinum toxin type A is about 1.4 IU/kg to 17.1 IU/kg of botulinum toxin type A. 10. The method of claim 7, wherein the therapeutically effective amount of botulinum toxin type A is 200 IU of botulinum toxin type A. 11. The method of claim 7, wherein the therapeutically effective amount of botulinum toxin type A is 400 IU of botulinum toxin type A.

Details for Patent 7,429,387

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	BOTOX COSMETIC	onabotulinumtoxina	For Injection	103000	December 09, 1991	⤷ Sign Up	2017-07-15
Abbvie Inc.	BOTOX	onabotulinumtoxina	For Injection	103000	December 09, 1991	⤷ Sign Up	2017-07-15
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,429,387

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Austria	E314085	⤷ Sign Up
Austria	E320815	⤷ Sign Up
Austria	E339220	⤷ Sign Up
Austria	E448792	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.